Effects of 4-Hexylresorcinol on Protein Expressions in RAW 264.7 Cells as Determined by Immunoprecipitation High Performance Liquid Chromatography

4-Hexylresorcinol (4HR) is a small organic compound that is used as an additive antiseptic and antioxidant, but its molecular properties have not been clearly elucidated. The present study explored the cellular effects of 4HR on RAW 264.7 cells by immunoprecipitation high-performance liquid chromatography (IP-HPLC) using 216 antisera. 4HR-treated cells showed significant decreases in the expressions of proliferation-related proteins, cMyc/MAX/MAD network, p53/Rb/E2F and Wnt/β-catenin signalings, epigenetic modifications, and protein translation. Furthermore, 4HR suppressed the expressions of growth factors and proteins associated with RAS signaling, NFkB signaling, inflammation, and osteogenesis, but elevated the expressions of proteins associated with p53-mediated and FAS-mediated apoptosis, T-cell immunity, angiogenesis, antioxidant, and oncogenic signaling. In a 4HR adherence assay, TNFα, PKC, osteopontin, and GADD45 were strongly adherent to 4HR-coated beads, whereas IL-6, c-caspase 3, CDK4, and c-caspase 9 were not. Many 4HR adherent proteins were expressed at lower levels in 4HR treated RAW 264.7 cells than in non-treated controls, whereas 4HR non-adherent proteins were expressed at higher levels. These observations suggest 4HR affects the expressions of proteins in an adhesion-dependent manner and that its effects on proteins are characteristic and global in RAW 264.7 cells.

Medienart:

E-Artikel

Erscheinungsjahr:

2019

Erschienen:

2019

Enthalten in:

Zur Gesamtaufnahme - volume:9

Enthalten in:

Scientific reports - 9(2019), 1 vom: 04. März, Seite 3379

Sprache:

Englisch

Beteiligte Personen:

Kim, Min Keun [VerfasserIn]
Yoon, Cheol Soo [VerfasserIn]
Kim, Seong Gon [VerfasserIn]
Park, Young Wook [VerfasserIn]
Lee, Sang Shin [VerfasserIn]
Lee, Suk Keun [VerfasserIn]

Links:

Volltext

Themen:

Antioxidants
Hexylresorcinol
Journal Article
Proteins
R9QTB5E82N
Research Support, Non-U.S. Gov't

Anmerkungen:

Date Completed 22.09.2020

Date Revised 22.09.2020

published: Electronic

Citation Status MEDLINE

doi:

10.1038/s41598-019-38946-4

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM294578080